Next Article in Journal
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
Next Article in Special Issue
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
Previous Article in Journal
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
Previous Article in Special Issue
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(5), 624; https://doi.org/10.3390/ph15050624
Action Date Notes Link
article pdf uploaded. 18 May 2022 14:33 CEST Version of Record https://www.mdpi.com/1424-8247/15/5/624/pdf-vor
article xml file uploaded 25 May 2022 14:48 CEST Original file -
article xml uploaded. 25 May 2022 14:48 CEST Update https://www.mdpi.com/1424-8247/15/5/624/xml
article pdf uploaded. 25 May 2022 14:48 CEST Updated version of record https://www.mdpi.com/1424-8247/15/5/624/pdf
article html file updated 25 May 2022 14:50 CEST Original file -
article html file updated 25 May 2022 14:51 CEST Update -
article html file updated 3 August 2022 00:31 CEST Update https://www.mdpi.com/1424-8247/15/5/624/html
Back to TopTop